Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Cancer Genomics Centre · Institut Gustave Roussy · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
907
total citations
- FWCI
- 41.97
- Percentile
- 100%
- References
- 30
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Melanoma
- Cancer research
- Vemurafenib
- V600E
- MEK inhibitor
- Epidermal growth factor receptor
- MAPK/ERK pathway
- EGFR inhibitors
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.